A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)
Open Access
- 1 January 2016
- journal article
- Published by Elsevier BV in Trials in Vaccinology
- Vol. 5, 92-96
- https://doi.org/10.1016/j.trivac.2016.04.004
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysisVaccine, 2015
- The Burden and Etiology of Community-Onset Pneumonia in the Aging Japanese Population: A Multicenter Prospective StudyPLOS ONE, 2015
- Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001–2012Vaccine, 2015
- Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009–2011Eurosurveillance, 2014
- Epidemiology of pneumococcal disease in a national cohort of older adults.Infectious Diseases and Therapy, 2014
- Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactionsThe Lancet Respiratory Medicine, 2014
- High Incidence of Community-Acquired Pneumonia among Rapidly Aging Population in Japan: A Prospective Hospital-Based SurveillanceJapanese Journal of Infectious Diseases, 2014
- Disease burden of pneumonia in Korean adults aged over 50 years stratified by age and underlying diseasesThe Korean Journal of Internal Medicine, 2014
- Factors Influencing Early and Late Mortality in Adults with Invasive Pneumococcal Disease in Calgary, Canada: A Prospective Surveillance StudyPLOS ONE, 2013
- New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare qualityThorax, 2009